Loading data
AVXLNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 37.59 m USD | 41.84 m USD | 43.72 m USD | 37.92 m USD |
| Selling, general and administrative expense | 13.82 m USD | 11.04 m USD | 12.05 m USD | — |
| Operating profit | -51.41 m USD | -52.88 m USD | -55.76 m USD | -50.99 m USD |
| Profit before tax | -46.38 m USD | -43 m USD | -47.5 m USD | -47.62 m USD |
| Net income (reported basis) | -46.38 m USD | -43 m USD | -47.51 m USD | -47.98 m USD |
| Basic earnings per share | -0.54 USD/share | -0.52 USD/share | -0.6 USD/share | -0.62 USD/share |
| Diluted earnings per share | -0.54 USD/share | -0.52 USD/share | -0.6 USD/share | -0.62 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.